4.5 Article

Scintigraphic imaging of vertebral osteomyelitis with 111In-Biotin

Journal

SPINE
Volume 33, Issue 7, Pages E198-E204

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/BRS.0b013e31816960c9

Keywords

vertebral infection; In-111-Biotin scintigraphy; spine infection imaging

Ask authors/readers for more resources

Study Design. Early diagnosis of vertebral infection (hematogenous or postsurgical) is necessary to choose a correct therapy and to minimize dramatic complications. All patients suspected to have vertebral infection underwent radiologic imaging and In-111-Biotin scintigraphy. Objective. Biotin is a growth factor used by many bacteria. The aim of our study is to use In-111-Biotin to diagnose vertebral infections. Summary of Background Data. Magnetic resonance imaging, even if endowed with fairly good sensitivity and specificity, shows some limitations in the study of the onset of pathology and in postsurgical conditions. Conventional scintigraphic imaging, like bone scintigraphy with (99)mTc-MDP, Ga-67-citrate scintigraphy, or Positron Emission Tomography with [F-18] FDG, are limited by relatively low specificity; the use of Streptavidin/ In-111-Biotin scintigraphy, based on aspecific uptake of tracer in the site of infection, shows good results in term of sensibility and specificity but the use of heterologous protein might engender immunogenic reactions. Methods. All patients (pts) (n = 110) of the study underwent In-111-biotin scintigraphy 2 hours after intravenous injection of the tracer, 71 pts were suspected to have hematogenous vertebral infection (Group I) and 39 pts were suspected to have postsurgical infection (Group II). The reference for final diagnosis was either bacterial cultures, histopathologic analysis, and/ or clinical/ imaging follow-up for at least 1 year. Results. In-111-biotin scintigraphy showed a sensitivity of 84% and specificity of 98% in Group I and a sensitivity of 100% and specificity of 84% in Group II. Conclusion. Our results showed that In-111-Biotin scintigraphy possess high diagnostic accuracy. This technique is easy to perform and requires short imaging time-point after intravenous tracer injection. Moreover if In-111-Biotin uptake is due only to high proliferation rate of bacteria presents in site of infection, it will be further investigated to discriminate definitely bacterial from sterile inflammation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Hematology

Lipid modification induced by lipoprotein apheresis could mirrored mid-regional-pro-adrenomedullin plasma levels?

Carmen Corciulo, Beatrice Dal Pino, Daniela Visentini, Federico Bigazzi, Andrea Ripoli, Emanuela Sozio, Francesco Curcio, Carlo Tascini, Martina Fabris, Tiziana Sampietro, Francesco Sbrana

TRANSFUSION AND APHERESIS SCIENCE (2023)

Article Immunology

Linezolid Population Pharmacokinetics to Improve Dosing in Cardiosurgical Patients: Factoring a New Drug-Drug Interaction Pathway

Manjunath P. Pai, Pier Giorgio Cojutti, Valentina Gerussi, Paola Della Siega, Carlo Tascini, Federico Pea

Summary: Linezolid-induced myelosuppression is likely to occur in cardiosurgical patients due to reduced kidney function and potential drug interactions. Population modeling and simulation demonstrate that lower doses coupled with therapeutic drug monitoring are necessary in this vulnerable population. Thus, reducing the empiric linezolid doses in cardiosurgical patients may help avoid toxicities, and further studies are needed to verify potential drug interactions.

CLINICAL INFECTIOUS DISEASES (2023)

Article Environmental Sciences

Using Metaphors to Understand Suffering in COVID-19 Survivors: A Two Time-Point Observational Follow-Up Study

Alvisa Palese, Erica Visintini, Valentina Bressan, Federico Fonda, Stefania Chiappinotto, Luca Grassetti, Maddalena Peghin, Carlo Tascini, Matteo Balestrieri, Marco Colizzi

Summary: This study aims to collect COVID-19 survivors' experiences through metaphors and explore the association between metaphor orientation and socio-demographic variables. The findings indicate that COVID-19 patients tend to use negative-oriented metaphors, which increase over time. The study emphasizes the need for personalized healthcare strategies to address the long-term traumatic consequences of COVID-19.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2023)

Letter Oncology

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

Francesco Marchesi, Jon Salmanton-Garcia, Caterina Buquicchio, Federico Itri, Caroline Besson, Julio Davila-Valls, Sonia Martin-Perez, Luana Fianchi, Laman Rahimli, Giuseppe Tarantini, Federica Irene Grifoni, Mariarita Sciume, Jorge Labrador, Raul Cordoba, Alberto Lopez-Garcia, Nicola S. Fracchiolla, Francesca Farina, Emanuele Ammatuna, Antonella Cingolani, Daniel Garcia-Bordallo, Stefanie K. Graefe, Yavuz M. Bilgin, Michelina Dargenio, Tomas Jose Gonzalez-Lopez, Anna Guidetti, Tobias Lahmer, Esperanza Lavilla-Rubira, Gustavo-Adolfo Mendez, Lucia Prezioso, Martin Schoenlein, Jaap Van Doesum, Dominik Wolf, Ditte Stampe Hersby, Ferenc Magyari, Jens Van Praet, Verena Petzer, Carlo Tascini, Iker Falces-Romero, Andreas Glenthoj, Oliver A. Cornely, Livio Pagano

Summary: This study reports breakthrough COVID-19 infections in hematologic malignancies patients who received prophylactic tixagevimab/cilgavimab. Most patients had lymphoproliferative disorders and were infected with the omicron variant. The use of tixagevimab/cilgavimab appears to reduce the severity of COVID-19 in these patients, but further studies are needed to determine the optimal drug administration strategies for immunocompromised patients.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

Article Immunology

Antibody, cell-mediated response and infection susceptibility in allogeneic hematopoietic stem cell recipients after COVID-19 mRNA vaccination

Umberto Pizzano, Gabriele Facchin, Chiara Marcon, Martina Fabris, Marta Lisa Battista, Michela Cerno, Antonella Geromin, Martina Pucillo, Giuseppe Petruzzellis, Giampaolo Vianello, Giulia Battaglia, Roberto Peressutti, Lucrezia Grillone, Carlo Tascini, Francesco Curcio, Renato Fanin, Francesca Patriarca

Summary: We compared humoral responses and infection onset in patients undergoing allogeneic stem-cell transplantation (allo-SCT) after receiving anti-SARS-CoV-2 mRNA vaccine. We found that an interval shorter than 12 months between allo-SCT and first vaccine dose, as well as ongoing immunosuppression, were associated with deficiency in humoral and cellular response after two doses. The third dose induced a sustained and increased humoral response in the majority of patients, but those within 1 year after allo-SCT remained at a higher infection risk.

TRANSPLANT INFECTIOUS DISEASE (2023)

Article Medicine, General & Internal

Barotrauma during Noninvasive Respiratory Support in COVID-19 Pneumonia Outside ICU: The Ancillary COVIMIX-2 Study

Luigi Vetrugno, Cristian Deana, Nadia Castaldo, Alberto Fantin, Alessandro Belletti, Emanuela Sozio, Maria De Martino, Miriam Isola, Diego Palumbo, Federico Longhini, Gianmaria Cammarota, Savino Spadaro, Salvatore Maurizio Maggiore, Flavio Bassi, Carlo Tascini, Vincenzo Patruno

Summary: NIRS in COVID-19 patients outside the ICU carries a low risk of barotrauma, which is more common in older patients with more severe systemic disease. The type of NIRS does not seem to increase the risk. Escalation of respiratory support is associated with higher in-hospital mortality.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Infectious Diseases

Artificial Intelligence Can Guide Antibiotic Choice in Recurrent UTIs and Become an Important Aid to Improve Antimicrobial Stewardship

Tommaso Cai, Umberto Anceschi, Francesco Prata, Lucia Collini, Anna Brugnolli, Serena Migno, Michele Rizzo, Giovanni Liguori, Luca Gallelli, Florian M. E. Wagenlehner, Truls E. Bjerklund Johansen, Luca Montanari, Alessandro Palmieri, Carlo Tascini

Summary: By using an Artificial Neural Network (ANN), we can predict the clinical efficacy of empiric antimicrobial treatment for women with recurrent urinary tract infections (rUTIs). This study trained the ANN on data from 1043 women and found that it had a high sensitivity (87.8%) and specificity (97.3%) in predicting the clinical efficacy of empirical therapy.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Ampicillin and Ceftobiprole Combination for the Treatment of Enterococcus faecalis Invasive Infections: The Times They Are A-Changin

Simone Giuliano, Jacopo Angelini, Denise D'Elia, Monica Geminiani, Roberto Daniele Barison, Alessandro Giacinta, Assunta Sartor, Floriana Campanile, Francesco Curcio, Menino Osbert Cotta, Jason A. Roberts, Massimo Baraldo, Carlo Tascini

Summary: This study retrospectively analyzed the medical records of patients with E. faecalis infections in a university hospital. The combination of ampicillin and ceftobiprole achieved high clinical success and microbiological cure rates. Therapeutic drug monitoring helped optimize treatment efficacy with fewer side effects.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Safety and Efficacy of a Single Procedure of Extraction and Reimplantation of Infected Cardiovascular Implantable Electronic Device (CIED) in Comparison with Deferral Timing: An Observational Retrospective Multicentric Study

Carlo Tascini, Simone Giuliano, Vittorio Attanasio, Luca Segreti, Andrea Ripoli, Francesco Sbrana, Sergio Severino, Chiara Sordelli, Sara Hana Weisz, Agnese Zanus-Fortes, Gabriele Maria Leanza, Novella Carannante, Andrea Di Cori, Maria Grazia Bongiorni, Giulio Zucchelli, Stefano De Vivo

Summary: This study compares the outcome and safety of a single-procedure device extraction and contralateral implantation with the standard two-stage replacement for infected cardiovascular implantable electronic devices. There were no significant differences in mortality rates between the single-procedure group and the standard-of-care group. Therefore, single-procedure reimplantation with active antibiofilm therapy may be a feasible and effective therapeutic option.

ANTIBIOTICS-BASEL (2023)

Article Public, Environmental & Occupational Health

Italian good practice recommendations on management of persons with Long-COVID

Marina Giuliano, Dorina Tiple, Piergiuseppe Agostoni, Benedetta Armocida, Ludovico Biardi, Anna Rita Bonfigli, Andrea Campana, Maria Ciardi, Fabiano Di Marco, Marco Floridia, Paola Gnerre, Tiziana Grassi, Ignazio Grattagliano, Paola Kruger, Matilde Leonardi, Rocco Liguori, Elisabetta Pagani, Elisa Perger, Flavia Pricci, Marinella Ruggeri, Andrea Silenzi, Francesco Spannella, Carlo Tascini, Giulia Tete, Matteo Tosato, Simona Vecchi, Marika Villa, Graziano Onder

Summary: A significant number of people experience persistent or new symptoms after acute SARS-CoV-2 infection, known as Long-COVID. In Italy, dedicated health facilities were established for the management of Long-COVID, but there is significant variation in the services provided. To address this, a multidisciplinary panel was formed to create recommendations for the clinical management of Long-COVID.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Infectious Diseases

CEFTO-CURE study: CEFTObiprole Clinical Use in Real-lifE-a multi-centre experience in Italy

Ivan Gentile, Antonio Riccardo Buonomo, Silvia Corcione, Laurenza Paradiso, Daniele Roberto Giacobbe, Davide Fiore Bavaro, Giusy Tiseo, Francesca Sordella, Michele Bartoletti, Giulia Palmiero, Antonietta Vozza, Antonio Vena, Francesca Canta, Nicola Schiano Moriello, Paola Congera, Arta Karruli, Carlo Tascini, Pierluigi Viale, Valerio Del Bono, Marco Falcone, Sergio Carbonara, Malgorzata Karolina Mikulskan, Matteo Bassettie, Emanuele Durante-Mangonid, Francesco Giuseppe De Rosa, Alberto Enrico Maraolo

Summary: This study evaluated the use of Ceftobiprole in a real-world setting and found it to be a safe and effective therapeutic choice, particularly for pneumonia and hospital-acquired pneumonia. The study also identified factors associated with treatment success or fatal outcomes.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Article Microbiology

Pragmatic overview on acute bacterial and fungal infections of the central nervous system: a holistic update from diagnosis to treatment

Simone Giuliano, Sarah Flammini, Agnese Zanus-Fortes, Luca Montanari, Gabriele Maria Leanza, Vittorio Attanasio, Davide Pecori, Francesco Sbrana, Carlo Tascini

Summary: Although progress has led to a decline in meningitis infections, it remains a global threat with varying impacts across different regions. Timely recognition and treatment are crucial as it is a medical emergency. Diagnosis often requires invasive methods, and delays in treatment can result in mortality and long-term complications. It is essential to evaluate appropriate interventions to optimize treatment, prevent overuse of antimicrobials, and reduce negative outcomes. The World Health Organization (WHO) has developed a roadmap to reduce the burden of meningitis by 2030, but there is a need for updated guidelines due to the increasing availability of novel diagnostic methods and pharmacological interventions. This paper aims to summarize existing data and evidence and propose potential novel solutions to address this complex problem.

NEW MICROBIOLOGICA (2023)

Article Microbiology

Lactococcus lactis blood products contamination resulting in fatal human case: insights from a forensic case

Simone Giuliano, Andrea Scatena, Francesco Sbrana, Luca Martini, Alice Chiara Manetti, Carlo Tascini, Marco Di Paolo

Summary: Lactococcus species are low virulence micro-aerophilic Gram positive bacteria widely used in food fermentation processes. Although their pathogenic potential is low, L. lactis can cause infections, especially in immunocompromised hosts, and there is limited data on L. lactis infections from blood transfusion products. This case report describes the first instance of L. lactis infection from transfusion of blood products in an 82-year-old immunocompromised patient.

NEW MICROBIOLOGICA (2023)

Review Microbiology

Cefditoren: a clinical overview

Simone Giuliano, Angela Acquasanta, Luca Martini, Francesco Sbrana, Sarah Flammini, Carlo Tascini

Summary: This study provides an overview of the pharmacodynamics, pharmacokinetics, and clinical indications of cefditoren. Cefditoren is an oral third-generation cephalosporin with broad-spectrum activity against Gram-negative and Gram-positive bacteria, making it effective in treating respiratory tract and skin and skin structure infections.

NEW MICROBIOLOGICA (2023)

Letter Pediatrics

Doctors and their children: the Pandora's jar of infectious diseases

Francesco Sbrana, Cristiana Domenichini, Paola Bellacchi, Emanuela Sozio, Beatrice Dal Pino, Carlo Tascini

MINERVA PEDIATRICS (2023)

No Data Available